Bayer Hlthcare
1 products tracked · names used in filings: Bayer Hlthcare
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 24 Oct 2025🇺🇸 FDA approval
FDA approves Lynkuet (elinzanetant), a new medicine
Bayer Hlthcare; NDA219469; New molecular entity; capsule · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇺🇸 | Lynkuet elinzanetant | Approved | 2025-10-24 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.